Skip to content

Loading page…

Original disclosures,
open access.

Corporate sustainability reports for research and decisions.

Follow our research

Database

Sustainability reports
Countries
Exchanges
Sectors
Industries
Years
Statistics

Services

Reports
Packages
Solutions
Markdown
Enterprise licence
Coverage assurance
Download portal

About

About us
Clients
Research & news
Careers

Resources

Pricing
Questions & answers
API documentation
Contact
Become a Supporter

© 2026 SustainabilityReports.com. All rights reserved.

Privacy policy Terms of service

Evotec SE 2012 Annual Report with Sustainability Disclosures

Company: Evotec SE

Sector: Manufacturing

Country: Germany

Year: 2012

Type: Annual Report with Sustainability Disclosures

Pages: 120

Home
Evotec SE
2012 Annual Report with Sustainability Disclosures

Annual Report

Preview not available

Report overview

The report describes Evotec's 9% revenue growth in 2012 and its expanded drug-discovery partnerships, including licensing the CureBeta portfolio to Janssen. It also highlights sustainability initiatives at the Hamburg campus, where heat-recovery systems reduced overall electricity consumption by 8.57%.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2012
Period: 1 January 2012 – 31 December 2012
Publication date: 26 March 2013
Language
Pages
File size

Standards & Assurance

Standards

Other

Assurance

Statement included

ESG & Materiality

ESG data

Indicators available in this report:

Employees
Women on the board

Materiality

Assessment
Basis

Build your research dataset.

Original reports, structured indicators and machine-readable Markdown for your project.

Explore our services